STOCK TITAN

Artivion to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Artivion, Inc. (NYSE: AORT) has announced its participation in two upcoming investor conferences. The management team will present at the Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022, at 9:30 a.m. ET in Boston, with a live webcast available on the company’s website. Additionally, they will participate in the Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 15-16, 2022, with no webcast available. Artivion focuses on innovative solutions for aortic disease and markets products in over 100 countries.

Positive
  • None.
Negative
  • None.

ATLANTA, Aug. 3, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022 at the InterContinental Boston Hotel. The Company's presentation is scheduled to begin at 9:30 a.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page.  An archived copy of the webcast will be available for 90 days on the same website. 

Members of the management team will also participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on Monday, August 15, 2022 & Tuesday, August 16, 2022. Due to the format of this event no webcast will be available.

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:



Artivion

Gilmartin Group LLC

D. Ashley Lee             

Brian Johnston / Lynn Lewis                 

Executive Vice President &

Phone:  332-895-3222

Chief Financial Officer

investors@artivion.com

Phone: 770-419-3355




Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-301598835.html

SOURCE Artivion, Inc.

FAQ

When will Artivion present at the Canaccord Genuity conference?

Artivion will present at the Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022, at 9:30 a.m. ET.

Where can I watch the Artivion conference presentation?

The presentation will be available via live webcast on Artivion's website during the conference.

What dates is Artivion participating in the Needham Virtual Med Tech Conference?

Artivion will participate in the Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 15-16, 2022.

What products does Artivion focus on?

Artivion specializes in products for cardiac and vascular surgery, specifically for aortic diseases.

In how many countries does Artivion market its products?

Artivion markets its products in over 100 countries worldwide.

Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Stock Data

1.14B
41.89M
5.52%
86.14%
7.15%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
KENNESAW